Healthcare provider profile · identity verified

Sana Chams

Geriatric Medicine · JACKSON, MI · NPI 1730531146

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	531	177
Levothyroxine Sodium	Levothyroxine Sodium	434	121
Pravastatin Sodium	Pravastatin Sodium	365	118
Losartan Potassium	Losartan Potassium	360	120
Lisinopril	Lisinopril	357	123
Amlodipine Besylate	Amlodipine Besylate	324	118
Omeprazole	Omeprazole	306	101
Metoprolol Succinate	Metoprolol Succinate	271	84
Metformin Hcl	Metformin Hcl	213	60
Sertraline Hcl	Sertraline Hcl	182	64
Pantoprazole Sodium	Pantoprazole Sodium	164	55
Trazodone Hcl	Trazodone Hcl	164	59
Gabapentin	Gabapentin	143	53
Hydrochlorothiazide	Hydrochlorothiazide	141	39
Duloxetine Hcl	Duloxetine Hcl	139	47
Albuterol Sulfate Hfa	Albuterol Sulfate	138	63
Eliquis	Apixaban	120	31
Rosuvastatin Calcium	Rosuvastatin Calcium	114	40
Simvastatin	Simvastatin	111	37
Buspirone Hcl	Buspirone Hcl	103	29
Fluticasone Propionate	Fluticasone Propionate	103	54
Escitalopram Oxalate	Escitalopram Oxalate	97	37
Tamsulosin Hcl	Tamsulosin Hcl	96	34
Shingrix	Varicella-Zoster Ge/As01b/Pf	94	71
Montelukast Sodium	Montelukast Sodium	93	34
Furosemide	Furosemide	92	37
Atenolol	Atenolol	91	25
Metformin Hcl Er	Metformin Hcl	89	31
Ozempic	Semaglutide	89	26
Potassium Chloride	Potassium Chloride	89	32
Tramadol Hcl	Tramadol Hcl	89	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	32
Donepezil Hcl	Donepezil Hcl	81	23
Mounjaro	Tirzepatide	80	16
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	78	78
Metoprolol Tartrate	Metoprolol Tartrate	77	30
Citalopram Hbr	Citalopram Hydrobromide	76	25
Spironolactone	Spironolactone	72	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	31
Warfarin Sodium	Warfarin Sodium	63	23
Alprazolam	Alprazolam	62	19
Famotidine	Famotidine	61	21
Jardiance	Empagliflozin	57	21
Meloxicam	Meloxicam	57	28
Allopurinol	Allopurinol	55	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	23
Mirtazapine	Mirtazapine	50	25
Bupropion Xl	Bupropion Hcl	49	23
Dicyclomine Hcl	Dicyclomine Hcl	49	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	15
Venlafaxine Hcl Er	Venlafaxine Hcl	49	14
Ropinirole Hcl	Ropinirole Hcl	48	15
Clonazepam	Clonazepam	47	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	46	15
Pregabalin	Pregabalin	45	11
Carvedilol	Carvedilol	44	18
Clopidogrel	Clopidogrel Bisulfate	43	20
Januvia	Sitagliptin Phosphate	43	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	15
Telmisartan	Telmisartan	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	11
Ezetimibe	Ezetimibe	35	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Glimepiride	Glimepiride	34	11
Lovastatin	Lovastatin	34	11
Ventolin Hfa	Albuterol Sulfate	33	13
Fluoxetine Hcl	Fluoxetine Hcl	32	12
Quetiapine Fumarate	Quetiapine Fumarate	31	11
Estradiol	Estradiol	30	12
Paroxetine Hcl	Paroxetine Hcl	30	11
Oxybutynin Chloride	Oxybutynin Chloride	29	16
Oxybutynin Chloride Er	Oxybutynin Chloride	29	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	20
Cephalexin	Cephalexin	26	19
Synthroid	Levothyroxine Sodium	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	14
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Hydrocortisone	Hydrocortisone	24	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Klor-Con M20	Potassium Chloride	23	suppressed
Lorazepam	Lorazepam	23	12
Ondansetron Odt	Ondansetron	23	13
Alendronate Sodium	Alendronate Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Bumetanide	Bumetanide	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Methylprednisolone	Methylprednisolone	22	21
Triamcinolone Acetonide	Triamcinolone Acetonide	22	12
Xarelto	Rivaroxaban	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	12
Levetiracetam	Levetiracetam	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Azithromycin	Azithromycin	19	17
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	18	18
Aripiprazole	Aripiprazole	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	11
Sotalol	Sotalol Hcl	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Finasteride	Finasteride	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glipizide	Glipizide	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error